Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2022 | 9/30/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $153,440 | $129,120 | $122,796 | $331,042 |
| - Cash | $10,722 | $42,650 | $68,892 | $95,028 |
| + Debt | $2,768 | $2,880 | $4,667 | $4,849 |
| Enterprise Value | $145,486 | $89,350 | $58,571 | $240,863 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$53 | $0 | -$256 | -$264 |
| % Margin | – | – | – | – |
| EBITDA | $5,866 | $4,858 | -$2,997 | -$13,753 |
| % Margin | – | – | – | – |
| Net Income | $4,751 | $39,195 | $1,465 | -$13,997 |
| % Margin | – | – | – | – |
| EPS Diluted | 4,330.567 | 36,349.698 | 1,287.871 | -9,841.349 |
| % Growth | -88.1% | 2,722.5% | 113.1% | – |
| Operating Cash Flow | $5,471 | – | -$12,689 | -$15,099 |
| Capital Expenditures | $0 | – | $0 | $0 |
| Free Cash Flow | $5,471 | – | -$12,689 | -$15,099 |